Key points are not available for this paper at this time.
Mechanistic explorations of single and combined therapeutic strategies, along with studies of bioavailability and translational aspects, will comprise future work in optimizing redox-active drugs.
Batinić‐Haberle et al. (Tue,) studied this question.